1985
DOI: 10.1111/j.1365-2125.1985.tb05120.x
|View full text |Cite
|
Sign up to set email alerts
|

Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam.

Abstract: 1 Twelve healthy male volunteers received phenytoin 0.5 and 1 g, lamotrigine (a new anticonvulsant) 120 and 240 mg, diazepam 10 mg and placebo orally in a double-blind, cross-over, randomized trial.2 Maximum drug concentrations at 4 h, measured in plasma were 11.5 + 2.2 ,ug ml-' for phenytoin and 2.7 + 0.4 ,ug ml-' for lamotrigine. These levels were in the therapeutic range for phenytoin and the putative therapeutic range for lamotrigine.3 Side effects after diazepam (mainly sedation) and phenytoin (mainly uns… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
62
0
3

Year Published

1997
1997
2015
2015

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 135 publications
(69 citation statements)
references
References 26 publications
0
62
0
3
Order By: Relevance
“…Pharmaco-electroencephalography was measured to provide nonspecific measures of CNS functions [23]. EEG signals were obtained from leads Fz-Cz and Pz-Oz.…”
Section: Electroencephalographymentioning
confidence: 99%
“…Pharmaco-electroencephalography was measured to provide nonspecific measures of CNS functions [23]. EEG signals were obtained from leads Fz-Cz and Pz-Oz.…”
Section: Electroencephalographymentioning
confidence: 99%
“…This has been particularly noted with benzodiazepine sedation, in which sedation is significantly correlated with saliva levels [16]. This phenomenon was noted particularly in the PK group and could explain the transient increase in salivary levels to baseline levels that was seen, 10 min after the bolus administration of propofol and ketamine, when the level of sedation appeared to lighten.…”
Section: Discussionmentioning
confidence: 86%
“…The promising activity and tolerability of lamotrigine led to its progression to clinical studies, with phase I studies confirming its safety and potential superiority to established drugs such as phenytoin and diazepam [71]. Lamotrigine was first approved in 1994 as an antiepileptic drug for the treatment of partial seizures.…”
Section: Lamotriginementioning
confidence: 99%